Angioplasty Balloons Market: Global Industry Analysis and Forecast (2024-2030)

Angioplasty Balloons Market size was valued at USD 2.72 Bn. in 2023 and the Angioplasty Balloons revenue is expected to grow at a CAGR of 3.7% from 2024 to 2030, reaching nearly USD 3.51 Bn. by 2030.

Format : PDF | Report ID : SMR_2059

Angioplasty Balloons Market Overview:

Angioplasty balloons are medical devices utilized in surgical processes that are incorporated in the process of dilating and unblocking blood arteries that have been clogged up. Drug-eluting, normal, scoring, and cutting angioplasty balloons are some of the common types of angioplasty balloon designs. The growth of Angioplasty Balloons market is expected because angioplasty balloons are more effective than other conventional angioplasty treatments. In addition, there is a growing incidence of heart problems that evoke targeted, highly effective treatment options.

A greater number of angioplasty operations are carried out as a result of improvements in diagnostic methods and instruments for cardiovascular disorders that enable earlier identification and treatment. The market for angioplasty balloons is propelled by rising awareness of cardiovascular illnesses and the implementation of screening programmes that result in early diagnosis and intervention. Moreover, the demand for angioplasty catheters is expected to rise because of an aging population with diabetes and heart disease. Furthermore, the growing inclination towards minimally invasive procedures is anticipated to propel the market growth, since these procedures entail the use of angioplasty balloons and tiny incisions to identify and address the impacted blood arteries.

Angioplasty Balloons Market

To get more Insights: Request Free Sample Report

Angioplasty Balloons Market Dynamics:

Rising Incidences of Cardiovascular Diseases Propelling the Growth of the Market.

The need for angioplasty treatments is increased by the rising prevalence of cardiovascular diseases (CVDs), such as peripheral artery disease and coronary artery disease. This in turn propels the market for angioplasty balloons. Advances in angioplasty balloon technology, like the creation of cutting and drug-eluting balloons, increase treatment efficacy and broaden the Angioplasty Balloons Market. The need for angioplasty operations and related devices rises as the world's population ages and age-related cardiovascular problems become more common.

The market for angioplasty balloons is growing as a result of patient’s preference for less invasive procedures over traditional surgical techniques since they have shorter recovery periods, need fewer hospital stays, and have fewer complications. Favourable reimbursement regulations in several regions lead patients into opting for angioplasty procedures. Wider range of patients are able to afford angioplasty now hence use of financial support for market growth driving the growth of the Angioplasty Balloons Market.

High Costs of the Procedures and Devices Affect the Growth of the Market.

The high expense of angioplasty treatments and sophisticated balloons used in angioplasty, including drug-eluting balloons, a major obstacle, particularly in low and middle income nations where funds for healthcare are less. The lengthy and stringent regulatory approval procedures for medical equipment, such as angioplasty balloons, cause delays in the release of new goods onto the market. Even though angioplasty procedures are less invasive, they still result in consequences including restenosis (re-narrowing of the artery), which restrict their use and require further treatments.

Unfair access to medical treatment, especially in remote or underprivileged places, prevent improved angioplasty balloons from being widely used. Barriers based on geography and socioeconomic status are important to consider for the growth of the market. The demand for angioplasty balloons is impacted by the availability of substitute therapies for cardiovascular disorders, such as coronary artery bypass grafting (CABG), as well as more recent methods like bioresorbable vascular scaffolds affecting the growth of the market.

Angioplasty Balloons Market Segment Analysis:

By Type, normal balloons, scoring balloons, drug-eluting balloons, and cutting balloons are the several categories under which the Angioplasty Balloons are classified. According to estimates, the normal balloon segment is anticipated to continue to dominate the industry during the forecasted period and currently holds the largest revenue share in the angioplasty balloons market. The use of normal balloons in angioplasty is made possible by their high burst pressure, which is the highest pressure the balloon withstand before rupturing, and affordability. The angioplasty balloons market sector is growing because of advantages including improved lesion targeting, reduced risk, and better patency. All these factors are driving the growth of the segment in the market.

Angioplasty Balloons Market1

Angioplasty Balloons Market Regional Insight:

North America held the highest market share in the Angioplasty Balloons Market. The market is primarily driven by the existence of major competitors, increasing healthcare spending, and an increase in percutaneous coronary interventions. The area is also a hub for new product inventions and technological advancements related to catheters and angioplasty balloons, which supports the growth of the angioplasty balloon industry. Cardiovascular disorders, such as peripheral artery disease (PAD) and coronary artery disease (CAD), are comparatively common in North America. This incidence is influenced by a number of factors, including aging populations, sedentary lifestyles, and poor dietary practices.

North America has some of the highest per capita healthcare spending in the world, modern medical techniques like angioplasty are used more frequently in the region. The region's high rates of obesity, diabetes, and other lifestyle-related illnesses lead to an increase in the prevalence of cardiovascular ailments, which makes the use of angioplasty balloons necessary. Angioplasty balloons are still in high demand in North America since angioplasty is a common first line of treatment for many cardiovascular diseases. All these factors are fuelling the growth of the Angioplasty Balloons Market in the region.

Angioplasty Balloons Market2

Angioplasty Balloons Market Competitive Landscape:

On January 2023, The FDA approved the Stellarex 0.035” OTW Drug-coated Angioplasty Balloon from Philips Image Guided Therapy Corp. The FDA has expanded the indications for use to include re-opening blood vessels within a previously placed stent. The balloon is coated with paclitaxel, which may prevent arteries from narrowing again.
In September 2022, Advanced NanoTherapies, Inc. reported the U.S. FDA granted the company a Breakthrough Device designation for its SirPlux Duo Drug-Coated Balloon (DCB) for coronary artery disease in vessels less than 3.0mm.
In October 2022, MedAlliance's novel sirolimus-eluting balloon, SELUTION SLR received FDA Investigational Device Exemption (IDE) approval to initiate its coronary pivotal clinical trial.

Angioplasty Balloons Market Scope:

Angioplasty Balloons Market
Market Size in 2023	USD 2.72 Bn.
Market Size in 2030	USD 3.51 Bn.
CAGR (2024-2030)	3.7 %
Historic Data	2018-2022
Base Year	2023
Forecast Period	2024-2030
Segments	By Type Normal Balloons Scoring Balloons Drug-eluting balloons Cutting balloon
	By Application Peripheral Coronary
	By End Use Hospitals Ambulatory Surgical Centres Other End Users
Regional Scope	North America- United States, Canada, and Mexico Europe – UK, France, Germany, Italy, Spain, Sweden, Russia, and Rest of Europe Asia Pacific – China, India, Japan, South Korea, Australia, ASEAN, Rest of APAC Middle East and Africa - South Africa, GCC, Egypt, Rest of the Middle East and Africa South America – Brazil, Argentina, Rest of South America

Angioplasty Balloons Market Key Players:

SIS Medical
Poba Medical
Anchor Balloon
Infinity Angioplasty Balloon
Translumina Therapeutics
Medtronic
Johnson & Johnson Services, Inc.
Abbott
Terumo
B. Braun
Cook Medical
Angiodynamics
Merit Medical Systems
Boston Scientific Corporation
Koninklijke Philips N.V.
Becton, Dickinson and Company
BIOTRONIK
B. Braun SE
ENDOCOR GmbH & CO
CTK Biotech, Inc.

Buy Now

Request For Free sample

Frequently Asked Questions

1. What is the growth driver for the Angioplasty Balloons Market?

Rising incidences of cardiovascular diseases is the driver of the Angioplasty Balloons Market.

2. What is the challenge of the Angioplasty Balloons Market?

High Costs of the procedures and Devices is the challenge in the Angioplasty Balloons Market.

3. What is the projected Angioplasty Balloons Market size & and growth rate of the Market?

The Market size was valued at USD 2.72 Billion in 2023 and the total Market revenue is expected to grow at a CAGR of 3.7 % from 2024 to 2030, reaching nearly USD 3.51 Billion.

4. What segments are covered in the Angioplasty Balloons Market report?

The segments covered in the market report are by Type, Application and End Use.

1.   Research Methodology
1.1   Research Data
1.1.1.   Primary Data
1.1.2.   Secondary Data
1.2.   Market Size Estimation
1.2.1.   Bottom-Up Approach
1.2.2.   Top-Down Approach
1.3.   Market Breakdown and Data Triangulation
1.4.   Research Assumption
2.   Angioplasty Balloons Market: Executive Summary
2.1.   Market Overview
2.2.   Market Size (2023) and Forecast (2024 – 2030) and Y-O-Y%
2.3.   Market Size (USD) and Market Share (%) – By Segments and Regions
3.   Global Angioplasty Balloons Market: Competitive Landscape
3.1.   SMR Competition Matrix
3.2.   Key Players Benchmarking
3.2.1.   Company Name
3.2.2.   Headquarter
3.2.3.   Product Segment
3.2.4.   End-user Segment
3.2.5.   Y-O-Y%
3.2.6.   Revenue (2023)
3.2.7.   Profit Margin
3.2.8.   Market Share
3.2.9.   Company Locations
3.3.   Market Structure
3.3.1.   Market Leaders
3.3.2.   Market Followers
3.3.3.   Emerging Players
3.4.   Consolidation of the Market
3.4.1.   Strategic Initiatives and Developments
3.4.2.   Mergers and Acquisitions
3.4.3.   Collaborations and Partnerships
3.4.4.   New Product Launches and Innovations
4.   Angioplasty Balloons Market: Dynamics
4.1.   Angioplasty Balloons Market Trends by Region
4.1.1.   North America
4.1.2.   Europe
4.1.3.   Asia Pacific
4.1.4.   Middle East and Africa
4.1.5.   South America
4.2.   Angioplasty Balloons Market Drivers
4.3.   Angioplasty Balloons Market Restraints
4.4.   Angioplasty Balloons Market Opportunities
4.5.   Angioplasty Balloons Market Challenges
4.6.   PORTER’s Five Forces Analysis
4.6.1.   Intensity of the Rivalry
4.6.2.   Threat of New Entrants
4.6.3.   Bargaining Power of Suppliers
4.6.4.   Bargaining Power of Buyers
4.6.5.   Threat of Substitutes
4.7.   PESTLE Analysis
4.7.1.   Political Factors
4.7.2.   Economic Factors
4.7.3.   Social Factors
4.7.4.   Technological Factor
4.7.5.   Legal Factors
4.7.6.   Environmental Factors
4.8.   Technological Roadmap
4.9.   Value Chain Analysis
4.10.   Regulatory Landscape by Region
4.10.1.   North America
4.10.2.   Europe
4.10.3.   Asia Pacific
4.10.4.   Middle East and Africa
4.10.5.   South America
5.   Angioplasty Balloons Market: Global Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030)
5.1.   Angioplasty Balloons Market Size and Forecast, by Type (2023-2030)
5.1.1.   Normal Balloons
5.1.2.   Scoring Balloons
5.1.3.   Drug-eluting balloons
5.1.4.   Cutting balloon
5.2.   Angioplasty Balloons Market Size and Forecast, by Application (2023-2030)
5.2.1.   Peripheral
5.2.2.   Coronary
5.3.   Angioplasty Balloons Market Size and Forecast, by End Use (2023-2030)
5.3.1.   Hospitals
5.3.2.   Ambulatory Surgical Centres
5.3.3.   Other End Users
5.4.   Angioplasty Balloons Market Size and Forecast, by Region (2023-2030)
5.4.1.   North America
5.4.2.   Europe
5.4.3.   Asia Pacific
5.4.4.   Middle East and Africa
5.4.5.   South America
6.   North America Angioplasty Balloons Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030)
6.1.   North America Angioplasty Balloons Market Size and Forecast, by Type (2023-2030)
6.1.1.   Normal Balloons
6.1.2.   Scoring Balloons
6.1.3.   Drug-eluting balloons
6.1.4.   Cutting balloon
6.2.   North America Angioplasty Balloons Market Size and Forecast, by Application (2023-2030)
6.2.1.   Peripheral
6.2.2.   Coronary
6.3.   North America Angioplasty Balloons Market Size and Forecast, by End Use (2023-2030)
6.3.1.   Hospitals
6.3.2.   Ambulatory Surgical Centres
6.3.3.   Other End Users
6.4.   North America Angioplasty Balloons Market Size and Forecast, by Country (2023-2030)
6.4.1.   United States
6.4.2.   Canada
6.4.3.   Mexico
7.   Europe Angioplasty Balloons Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030)
7.1.   Europe Angioplasty Balloons Market Size and Forecast, by Type (2023-2030)
7.2.   Europe Angioplasty Balloons Market Size and Forecast, by Application (2023-2030)
7.3.   Europe Angioplasty Balloons Market Size and Forecast, by End Use (2023-2030)
7.4.   Europe Angioplasty Balloons Market Size and Forecast, by Country (2023-2030)
7.4.1.   United Kingdom
7.4.2.   France
7.4.3.   Germany
7.4.4.   Italy
7.4.5.   Spain
7.4.6.   Sweden
7.4.7.   Russia
7.4.8.   Rest of Europe
8.   Asia Pacific Angioplasty Balloons Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030)
8.1.   Asia Pacific Angioplasty Balloons Market Size and Forecast, by Type (2023-2030)
8.2.   Asia Pacific Angioplasty Balloons Market Size and Forecast, by Application (2023-2030)
8.3.   Asia Pacific Angioplasty Balloons Market Size and Forecast, by End Use (2023-2030)
8.4.   Asia Pacific Angioplasty Balloons Market Size and Forecast, by Country (2023-2030)
8.4.1.   China
8.4.2.   India
8.4.3.   Japan
8.4.4.   South Korea
8.4.5.   Australia
8.4.6.   ASEAN
8.4.7.   Rest of Asia Pacific
9.   Middle East and Africa Angioplasty Balloons Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030)
9.1.   Middle East and Africa Angioplasty Balloons Market Size and Forecast, by Type (2023-2030)
9.2.   Middle East and Africa Angioplasty Balloons Market Size and Forecast, by Application (2023-2030)
9.3.   Middle East and Africa Angioplasty Balloons Market Size and Forecast, by End Use (2023-2030)
9.4.   Middle East and Africa Angioplasty Balloons Market Size and Forecast, by Country (2023-2030)
9.4.1.   South Africa
9.4.2.   GCC
9.4.3.   Egypt
9.4.4.   Rest of the Middle East and Africa
10.   South America Angioplasty Balloons Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030)
10.1.   South America Angioplasty Balloons Market Size and Forecast, by Type (2023-2030)
10.2.   South America Angioplasty Balloons Market Size and Forecast, by Application (2023-2030)
10.3.   South America Angioplasty Balloons Market Size and Forecast, by End Use (2023-2030)
10.4.   South America Angioplasty Balloons Market Size and Forecast, by Country (2023-2030)
10.4.1.   Brazil
10.4.2.   Argentina
10.4.3.   Rest Of South America
11.   Company Profile: Key Players
11.1.   SIS Medical
11.1.1.   Company Overview
11.1.2.   Business Portfolio
11.1.2.1.   Product Name
11.1.2.2.   Product Details
11.1.3.   Financial Overview
11.1.3.1.   Total Revenue
11.1.3.2.   Segment Revenue
11.1.3.3.   Regional Revenue
11.1.4.   SWOT Analysis
11.1.5.   Strategic Analysis
11.1.6.   Recent Developments
11.2.   Poba Medical
11.3.   Anchor Balloon
11.4.   Infinity Angioplasty Balloon
11.5.   Translumina Therapeutics
11.6.   Medtronic
11.7.   Johnson & Johnson Services, Inc.
11.8.   Abbott
11.9.   Terumo
11.10.   B. Braun
11.11.   Cook Medical
11.12.   Angiodynamics
11.13.   Merit Medical Systems
11.14.   Boston Scientific Corporation
11.15.   Koninklijke Philips N.V.
11.16.   Becton, Dickinson and Company
11.17.   BIOTRONIK
11.18.   B. Braun SE
11.19.   ENDOCOR GmbH & CO
11.20.   CTK Biotech, Inc.
12.   Key Findings
13.   Analyst Recommendations
13.1.   Strategic Recommendations
13.2.   Future Outlook